Company research / IDXG
INTERPACE BIOSCIENCES, INC. (IDXG)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, INTERPACE BIOSCIENCES, INC. reported revenue of $38.73M. Revenue fell 17.5% from the prior annual period.
Key ratios (year ended 2025-12-31)
62.3%
Gross margin
10.5%
Operating margin
63.5%
Net margin
109.9%
Return on year-end equity
-17.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.